Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
Brady L, Newcomb LF, Zhu K, Zheng Y, Boyer H, Sarkar N, McKenney JK, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, Morgan TM, Thompson IM, Wagner AA, Pritchard CC, Lin DW, Nelson PS.
Brady L, et al. Among authors: carroll pr.
Cancer Med. 2022 Nov;11(22):4332-4340. doi: 10.1002/cam4.4778. Epub 2022 Apr 25.
Cancer Med. 2022.
PMID: 35467778
Free PMC article.